Media Centre
Latest press releases
-
Truqap plus Faslodex recommended for approval in the EU by CHMP for patients with advanced ER-positive breast cancer
-
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one or more lines of endocrine therapy in DESTINY-Breast06 Phase III trial
-
Q1 2024 results
-
Voydeya approved in the EU as add-on treatment to ravulizumab or eculizumab for adults with the rare disease PNH who have residual haemolytic anaemia
-
AstraZeneca advances the science of infectious disease protection at ECCMID 2024
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
